Last week, we made the decision to shut down Endpoints MarketingRx. Over the last year, Endpoints News has put more resources into our core biopharma and healthcare coverage, and into work where we’re ...
Eli Lilly will face questions from a panel of Alzheimer's experts on June 10, setting up an approval decision for donanemab after a surprise delay by the FDA in early March. The drug will go before ...
Transcarent’s $126 million Series D round, which in May bumped its valuation to $2.2 billion, stands apart from most growth-stage, high-valuation startups that haven't raised capital in the past few ...
In the bid to lock up patent rights to a growing suite of gene-editing technologies, Arbor Biotechnologies has acquired a small startup founded by MIT scientist and CRISPR pioneer Feng Zhang, the ...
In the midst of the Covid-19 pandemic, while most scientists were busy plotting new ways to combat viruses, one startup quietly began a counterintuitive campaign: getting viruses to work for us, ...
Vertex said it's making strong progress bringing its CRISPR Therapeutics-partnered gene therapy to patients after a landmark approval for sickle cell disease in December. Chief operating officer ...
Illumina prefers to spin off Grail into an independent business rather than selling the cancer diagnostics company, according to a financial document released Monday that describes the Illumina ...
The University of Pennsylvania’s pioneering cell therapy physician Carl June shared new data Monday that showed the risk of ...
Senate HELP committee ranking member Bill Cassidy (R-LA) is calling on the Biden administration to do a better job of ...
ADC Ther­a­peu­tics an­nounced a $105 mil­lion of­fer­ing af­ter shar­ing what it called pos­i­tive topline da­ta from a ...
In the first of what's expected to be a series of REMS-related advice for the industry, the FDA on Monday unveiled new draft ...
Plus, news about EyePoint, Lyra Therapeutics and Plus Therapeutics: For global health, $300 million: The Bill & Melinda Gates Foundation, the Novo Nordisk Foundation and Wellcome are each pitching in ...